المؤلفون: Tavares CAM; Hospital Israelita Albert Einstein, São Paulo, São Paulo, Brazil.; Geriatric Cardiology Unit, Instituto do Coração do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil., Azevedo LCP; Hospital Israelita Albert Einstein, São Paulo, São Paulo, Brazil., Rea-Neto Á; Center for Studies and Research in Intensive Care Medicine, Curitiba, Brazil.; Internal Medicine Department, Hospital de Clínicas, Federal University of Paraná, Curitiba, Brazil.; Hospital Santa Casa Curitiba, Curitiba, Brazil., Campos NS; Hospital Israelita Albert Einstein, São Paulo, São Paulo, Brazil.; Hospital M´Boi Mirim, São Paulo, Brazil., Amendola CP; Hospital de Câncer de Barretos, Barretos, Brazil., Kozesinski-Nakatani AC; Center for Studies and Research in Intensive Care Medicine, Curitiba, Brazil.; Internal Medicine Department, Hospital de Clínicas, Federal University of Paraná, Curitiba, Brazil.; Hospital Santa Casa Curitiba, Curitiba, Brazil., David-João PG; Hospital M´Boi Mirim, São Paulo, Brazil., Lobo SM; Intensive Care Division, Hospital de Base, Faculdade de Medicina de São José do Rio Preto, São José do Rio Preto, Brazil., Filiponi TC; Hospital Universitário São Francisco de Assis na Providência de Deus, Bragança Paulista, Brazil., Almeida GMB; Hospital de Emergência Dr Daniel Houly, Arapiraca, Brazil., Bergo RR; Hospital Santa Lucia, Poços de Caldas, Brazil., Guimarães-Júnior MRR; Santa Casa de Misericórdia de Barretos, Barretos, Brazil., Figueiredo RC; Hospital Maternidade São José, Colatina, Brazil., Castro JR; Hospital Municipal de Aparecida de Goiânia, Aparecida de Goiânia, Brazil., Schuler CJ; Hospital Nossa Senhora de Oliveira, Vacaria, Brazil., Westphal GA; Centro Hospitalar Unimed, Joinville, Brazil., Carioca ACR; Hospital Israelita Albert Einstein, São Paulo, São Paulo, Brazil., Monfradini F; Hospital Israelita Albert Einstein, São Paulo, São Paulo, Brazil., Nieri J; Hospital Israelita Albert Einstein, São Paulo, São Paulo, Brazil., Neves FMO; Hospital Israelita Albert Einstein, São Paulo, São Paulo, Brazil., Paulo JA; Hospital Israelita Albert Einstein, São Paulo, São Paulo, Brazil., Albuquerque CSN; Hospital Israelita Albert Einstein, São Paulo, São Paulo, Brazil., Silva MCR; Hospital Israelita Albert Einstein, São Paulo, São Paulo, Brazil., Kosiborod MN; Department of Cardiovascular Disease, Saint Luke's Mid America Heart Institute, University of Missouri-Kansas City School of Medicine, Kansas City., Pereira AJ; Hospital Israelita Albert Einstein, São Paulo, São Paulo, Brazil., Damiani LP; Hospital Israelita Albert Einstein, São Paulo, São Paulo, Brazil., Corrêa TD; Hospital Israelita Albert Einstein, São Paulo, São Paulo, Brazil., Serpa-Neto A; Hospital Israelita Albert Einstein, São Paulo, São Paulo, Brazil.; Australian and New Zealand Intensive Care Research Centre, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.; Department of Intensive Care, Austin Hospital, Melbourne, Australia., Berwanger O; Hospital Israelita Albert Einstein, São Paulo, São Paulo, Brazil.; George Institute for Global Health, London, United Kingdom.; Imperial College London, London, United Kingdom., Zampieri FG; Hospital Israelita Albert Einstein, São Paulo, São Paulo, Brazil.; Department of Critical Care Medicine, Faculty of Medicine and Dentistry, University of Alberta and Alberta Health Services, Edmonton, Canada.

مؤلفون مشاركون: DEFENDER Investigators

المصدر: JAMA [JAMA] 2024 Aug 06; Vol. 332 (5), pp. 401-411.

نوع المنشور: Journal Article; Randomized Controlled Trial; Multicenter Study; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited Medium: Internet ISSN: 1538-3598 (Electronic) Linking ISSN: 00987484 NLM ISO Abbreviation: JAMA Subsets: MEDLINE

مواضيع طبية MeSH: Benzhydryl Compounds*/therapeutic use , Glucosides*/therapeutic use , Glucosides*/adverse effects , Critical Illness* , Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use , Sodium-Glucose Transporter 2 Inhibitors*/adverse effects , Intensive Care Units* , Length of Stay* , Hospital Mortality*, Humans ; Female ; Male ; Middle Aged ; Aged ; Renal Replacement Therapy ; Multiple Organ Failure/drug therapy